Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-May 2014. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2105001000001116 | Mylafent 12micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 2105021000001111 | Mylafent 12micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 79846701000001112 | Mylafent 12micrograms/hour transdermal patches (Generics (UK) Ltd) (product) | en | Fully specified name | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 79846801000001115 | Mylafent 12micrograms/hour transdermal patches (Generics (UK) Ltd) | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 92727101000001118 | Mylafent 12micrograms/hour transdermal patches (Mylan Ltd) | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 105628401000001116 | Mylafent 12micrograms/hour transdermal patches (Mylan) | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Mylafent 12micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) 5 patch | Has AMP | True | Mylafent 12micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets